Jacobs Levy Equity Management
DVAX

Jacobs Levy Equity Management’s Dynavax Technologies DVAX Stock Holding History

Jacobs Levy Equity Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-118,484
Closed -$1.18M – 961
2025
Q3 		$1.18M Buy
118,484
+1,610
+1% +$16.8K ﹤0.01% 686
2025
Q2 		$1.16M Sell
116,874
-74,131
-39% -$781K ﹤0.01% 729
2025
Q1 		$2.48M Buy
+191,005
New +$2.53M 0.01% 610
2014
Q3 		– Sell
-1,310
Closed -$21K – 839
2014
Q2 		$21K Buy
+1,310
New +$19.8K ﹤0.01% 822
2014
Q1 		– Sell
-83,182
Closed -$1.63M – 917
2013
Q4 		$1.63M Buy
83,182
+30,885
+59% +$452K 0.02% 467
2013
Q3 		$622K Buy
+52,297
New +$658K 0.01% 631

Other funds holding DVAX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jacobs Levy Equity Management's DVAX Position: Q4 2025 in Review

Jacobs Levy Equity Management sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 118,484 shares — an estimated $1.18M sold.

Jacobs Levy Equity Management first reported a position in DVAX in Q3 2013 and held it in 6 quarters. The position peaked at $2.48M in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Jacobs Levy Equity Management reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 118,484 Dynavax Technologies shares in Q4 2025, an estimated $1.18M.
  • Jacobs Levy Equity Management first reported a position in Dynavax Technologies in Q3 2013 and held it in 6 quarters.
  • Jacobs Levy Equity Management's Dynavax Technologies position peaked at $2.48M in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2025, filed 13 Feb 2026.